Boston Scientific Acquiring Penumbra Was The Logical Next Step

2026-01-15 12:10:25 ET

Already one of the best growth stories in med-tech, Boston Scientific ( BSX ) has once again turned to M&A to not only bolster its growth profile but also fill one of the relatively few obvious gaps in the portfolio. Acquiring Penumbra ( PEN ) will be expensive and dilutive up front, but the deal adds billions of dollars in potential revenue (with a strong growth rate and healthy profitability), and I believe Boston Scientific can accelerate Penumbra’s growth above and beyond what the company could have done on its own....

Read the full article on Seeking Alpha

For further details see: